Knockdown of core binding factorβ alters sphingolipid metabolism

Journal of Cellular Physiology

Volumn 228, Issue 12, 2013, Pages 2350-2364

  Greer, Adam H ^a   Yong, Thomas ^a   Fennell, Katie ^a   Moustafa, Yara W ^a   Fowler, Marcie ^b   Galiano, Floyd ^a   Ng, Shu Wing ^c   Berkowitz, Ross S ^c   Cardelli, James ^a   Meyers, Shari ^a   Davis, J Nathan ^d  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Army Institute of Surgical Research   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Quinnipiac University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CORE BINDING FACTOR BETA; LACTOSYLCERAMIDE; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA; SPHINGOLIPID; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX3;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL CYCLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIPID METABOLISM; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD; APOPTOSIS; AUTOPHAGY; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR BETA SUBUNIT; DNA-BINDING PROTEINS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; LACTOSYLCERAMIDES; OVARIAN NEOPLASMS; REACTIVE OXYGEN SPECIES; SPHINGOLIPIDS;

EID: 84882968571     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24406     Document Type: Article

References (58)

1. Adya N, Castilla LH, Liu PP. 2000. Function of CBFbeta/Bro proteins. Semin Cell Dev Biol 11:361-368.
2. Backstrom S, Wolf-Watz M, Grundstrom C, Hard T, Grundstrom T, Sauer UH. 2002. The RUNX1 runt domain at 1.25A resolution: A structural switch and specifically bound chloride ions modulate DNA binding. J Mol Biol 322:259-272.
3. Bae SC, Choi JK. 2004. Tumor suppressor activity of RUNX3. Oncogene 23:4336-4340.
4. Bartke N, Hannun YA. 2009. Bioactive sphingolipids: Metabolism and function. J Lipid Res S91-S96.
5. Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Metivier D, Meley D, Souquere S, Yoshimori T, Pierron G, Codogno P, Kroemer G. 2005. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25:1025-1040.
6. Braig M, Schmitt CA. 2006. Oncogene-induced senescence: Putting the brakes on tumor development. Cancer Res 66:2881-2884.
7. Cameron ER, Blyth K, Hanlon L, Kilbey A, Mackay N, Stewart M, Terry A, Vaillant F, Wotton S, Neil JC. 2003. The Runx genes as dominant oncogenes. Blood Cells Mol Dis 30:194-200.
8. Cameron ER, Neil JC. 2004. The Runx genes: Lineage-specific oncogenes and tumor suppressors. Oncogene 23:4308-4314.
9. Chen Y, McMillan-Ward E, Kong J, Israels SJ, Gibson SB. 2008. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ 15:171-182.
10. Cunningham L, Finckbeiner S, Hyde RK, Southall N, Marugan J, Yedavalli VR, Dehdashti SJ, Reinhold WC, Alemu L, Zhao L, Yeh JR, Sood R, Pommier Y, Austin CP, Jeang KT, Zheng W, Liu P. 2012. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFbeta interaction. Proc Natl Acad Sci USA 109:14592-14597.
11. Davis JN, Rogers D, Adams L, Yong T, Jung JS, Cheng B, Fennell K, Borazanci E, Moustafa YW, Sun A, Shi R, Glass J, Mathis JM, Williams BJ, Meyers S. 2010. Association of core-binding factor beta with the malignant phenotype of prostate and ovarian cancer cells. J Cell Physiol 225:875-887.
12. de Bruijn MF, Speck NA. 2004. Core-binding factors in hematopoiesis and immune function. Oncogene 23:4238-4248.
13. Dikalov SI, Harrison DG. Methods for detection of mitochondrial and cellular reactive oxygen species. Antioxid Redox Signal, ahead of print, doi:10.1089/ars.2012.4886
14. Durst KL, Hiebert SW. 2004. Role of RUNX family members in transcriptional repression and gene silencing. Oncogene 23:4220-4224.
15. Fowler M, Borazanci E, McGhee L, Pylant SW, Williams BJ, Glass J, Davis JN, Meyers S. 2006. RUNX1 (AML-1) and RUNX2 (AML-3) co-operate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region. J Cell Biochem 97:1-17.
16. Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandez-Checa JC. 1997. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem 272:11369-11377.
17. Gault CR, Obeid LM, Hannun YA. 2010. An overview of sphingolipid metabolism: From synthesis to breakdown. Adv Exp Med Biol 688:1-23.
18. Gorczynski MJ, Grembecka J, Zhou Y, Kong Y, Roudaia L, Douvas MG, Newman M, Bielnicka I, Baber G, Corpora T, Shi J, Sridharan M, Lilien R, Donald BR, Speck NA, Brown ML, Bushweller JH. 2007. Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta. Chem Biol 14:1186-1197.
19. Goyama S, Yamaguchi Y, Imai Y, Kawazu M, Nakagawa M, Asai T, Kumano K, Mitani K, Ogawa S, Chiba S, Kurokawa M, Hirai H. 2004. The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region. Blood 104:3558-3564.
20. Gozuacik D, Kimchi A. 2007. Autophagy and cell death. Curr Top Dev Biol 78:217-245.
21. Grosch S, Schiffmann S, Geisslinger G. 2012. Chain length-specific properties of ceramides. Prog Lipid Res 51:50-62.
22. Hajra A, Collins FS. 1995. Structure of the leukemia-associated human CBFB gene. Genomics 26:571-579.
23. Hansen TE, Johansen T. 2011. Following autophagy step by step. BMC Biol 9:39.
24. Hiebert SW, Sun W, Davis JN, Golub T, Shurtleff S, Buijs A, Downing JR, Grosveld G, Roussell MF, Gilliland DG, Lenny N, Meyers S. 1996. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol 16:1349-1355.
25. Huang G, Shigesada K, Ito K, Wee HJ, Yokomizo T, Ito Y. 2001. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J 20:723-733.
26. Huang SP, Lan YH, Lu TL, Pao JB, Chang TY, Lee HZ, Yang WH, Hsieh CJ, Chen LM, Huang LC, Ting WC, Bao BY. 2011. Clinical significance of runt-related transcription factor 1 polymorphism in prostate cancer. BJU Int 107:486-492.
27. Huang X, Peng JW, Speck NA, Bushweller JH. 1999. Solution structure of core binding factor beta and map of the CBF alpha binding site. Nat Struct Biol 6:624-627.
28. Kilbey A, Terry A, Cameron ER, Neil JC. 2008. Oncogene-induced senescence: An essential role for Runx. Cell Cycle 7:2333-2340.
29. Kilbey A, Terry A, Jenkins A, Borland G, Zhang Q, Wakelam MJ, Cameron ER, Neil JC. 2010. Runx regulation of sphingolipid metabolism and survival signaling. Cancer Res 70:5860-5869.
30. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, Bamber BA, Bassham DC, Bergamini E, Bi X, Biard-Piechaczyk M, Blum JS, Bredesen DE, Brodsky JL, Brumell JH, Brunk UT, Bursch W, Camougrand N, Cebollero E, Cecconi F, Chen Y, Chin LS, Choi A, Chu CT, Chung J, Clarke PG, Clark RS, Clarke SG, Clave C, Cleveland JL, Codogno P, Colombo MI, Coto-Montes A, Cregg JM, Cuervo AM, Debnath J, Demarchi F, Dennis PB, Dennis PA, Deretic V, Devenish RJ, Di Sano F, Dice JF, Difiglia M, Dinesh-Kumar S, Distelhorst CW, Djavaheri-Mergny M, Dorsey FC, Droge W, Dron M, Dunn WA, Jr, Duszenko M, Eissa NT, Elazar Z, Esclatine A, Eskelinen EL, Fesus L, Finley KD, Fuentes JM, Fueyo J, Fujisaki K, Galliot B, Gao FB, Gewirtz DA, Gibson SB, Gohla A, Goldberg AL, Gonzalez R, Gonzalez-Estevez C, Gorski S, Gottlieb RA, Haussinger D, He YW, Heidenreich K, Hill JA, Hoyer-Hansen M, Hu X, Huang WP, Iwasaki A, Jaattela M, Jackson WT, Jiang X, Jin S, Johansen T, Jung JU, Kadowaki M, Kang C, Kelekar A, Kessel DH, Kiel JA, Kim HP, Kimchi A, Kinsella TJ, Kiselyov K, Kitamoto K, Knecht E, Komatsu M, Kominami E, Kondo S, Kovacs AL, Kroemer G, Kuan CY, Kumar R, Kundu M, Landry J, Laporte M, Le W, Lei HY, Lenardo MJ, Levine B, Lieberman A, Lim KL, Lin FC, Liou W, Liu LF, Lopez-Berestein G, Lopez-Otin C, Lu B, Macleod KF, Malorni W, Martinet W, Matsuoka K, Mautner J, Meijer AJ, Melendez A, Michels P, Miotto G, Mistiaen WP, Mizushima N, Mograbi B, Monastyrska I, Moore MN, Moreira PI, Moriyasu Y, Motyl T, Munz C, Murphy LO, Naqvi NI, Neufeld TP, Nishino I, Nixon RA, Noda T, Nurnberg B, Ogawa M, Oleinick NL, Olsen LJ, Ozpolat B, Paglin S, Palmer GE, Papassideri I, Parkes M, Perlmutter DH, Perry G, Piacentini M, Pinkas-Kramarski R, Prescott M, Proikas-Cezanne T, Raben N, Rami A, Reggiori F, Rohrer B, Rubinsztein DC, Ryan KM, Sadoshima J, Sakagami H, Sakai Y, Sandri M, Sasakawa C, Sass M, Schneider C, Seglen PO, Seleverstov O, Settleman J, Shacka JJ, Shapiro IM, Sibirny A, Silva-Zacarin EC, Simon HU, Simone C, Simonsen A, Smith MA, Spanel-Borowski K, Srinivas V, Steeves M, Stenmark H, Stromhaug PE, Subauste CS, Sugimoto S, Sulzer D, Suzuki T, Swanson MS, Tabas I, Takeshita F, Talbot NJ, Talloczy Z, Tanaka K, Tanida I, Taylor GS, Taylor JP, Terman A, Tettamanti G, Thompson CB, Thumm M, Tolkovsky AM, Tooze SA, Truant R, Tumanovska LV, Uchiyama Y, Ueno T, Uzcategui NL, van der Klei I, Vaquero EC, Vellai T, Vogel MW, Wang HG, Webster P, Wiley JW, Xi Z, Xiao G, Yahalom J, Yang JM, Yap G, Yin XM, Yoshimori T, Yu L, Yue Z, Yuzaki M, Zabirnyk O, Zheng X, Zhu X, Deter RL. 2008. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4:151-175.
31. Kundu M, Javed A, Jeon JP, Horner A, Shum L, Eckhaus M, Muenke M, Lian JB, Yang Y, Nuckolls GH, Stein GS, Liu PP. 2002. Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat Genet 32:639-644.
32. Levanon D, Bettoun D, Harris-Cerruti C, Woolf E, Negreanu V, Eilam R, Bernstein Y, Goldenberg D, Xiao C, Fliegauf M, Kremer E, Otto F, Brenner O, Lev-Tov A, Groner Y. 2002. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J 21:3454-3463.
33. Levanon D, Groner Y. 2004. Structure and regulated expression of mammalian RUNX genes. Oncogene 23:4211-4219.
34. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y. 1994. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23:425-432.
35. Liu YY, Han TY, Giuliano AE, Cabot MC. 2001. Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J 15:719-730.
36. Look AT. 1997. Oncogenic transcription factors in the human acute leukemias. Science 278:1059-1064.
37. Marchi S, Giorgi C, Suski JM, Agnoletto C, Bononi A, Bonora M, De Marchi E, Missiroli S, Patergnani S, Poletti F, Rimessi A, Duszynski J, Wieckowski MR, Pinton P. 2011. Mitochondria-ros crosstalk in the control of cell death and aging. J Signal Transduct 2012:329635.
38. Meyers S, Downing JR, Hiebert SW. 1993. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: The runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol 13:6336-6345.
39. Meyers S, Lenny N, Sun W, Hiebert SW. 1996. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene 13:303-312.
40. Mullen TD, Jenkins RW, Clarke CJ, Bielawski J, Hannun YA, Obeid LM. 2011. Ceramide synthase-dependent ceramide generation and programmed cell death: Involvement of salvage pathway in regulating postmitochondrial events. J Biol Chem 286:15929-15942.
41. Nevadunsky NS, Barbieri JS, Kwong J, Merritt MA, Welch WR, Berkowitz RS, Mok SC. 2009. RUNX3 protein is overexpressed in human epithelial ovarian cancer. Gynecol Oncol 112:325-330.
42. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321-330.
43. Osato M. 2004. Point mutations in the RUNX1/AML1 gene: Another actor in RUNX leukemia. Oncogene 23:4284-4296.
44. Pettus BJ, Chalfant CE, Hannun YA. 2002. Ceramide in apoptosis: An overview and current perspectives. Biochim Biophys Acta 1585:114-125.
45. Pratap J, Javed A, Languino LR, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 2005. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol 25:8581-8591.
46. Pratap J, Lian JB, Javed A, Barnes GL, van Wijnen AJ, Stein JL, Stein GS. 2006. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metast Rev 25:589-600.
47. San Martin IA, Varela N, Gaete M, Villegas K, Osorio M, Tapia JC, Antonelli M, Mancilla EE, Pereira BP, Nathan SS, Lian JB, Stein JL, Stein GS, van Wijnen AJ, Galindo M. 2009. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells. J Cell Physiol 221:560-571.
48. Scarlatti F, Granata R, Meijer AJ, Codogno P. 2009. Does autophagy have a license to kill mammalian cells? Cell Death Differ 16:12-20.
49. Schwarzer C, Illek B, Suh JH, Remington SJ, Fischer H, Machen TE. 2007. Organelle redox of CF and CFTR-corrected airway epithelia. Free Radic Biol Med 43:300-316.
50. Suh J, Payvandi F, Edelstein LC, Amenta PS, Zong WX, Gelinas C, Rabson AB. 2002. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate 52:183-200.
51. Thorburn A. 2008a. Apoptosis and autophagy: Regulatory connections between two supposedly different processes. Apoptosis 13:1-9.
52. Thorburn A. 2008b. Studying autophagy's relationship to cell death. Autophagy 4:391-394.
53. Van Brocklyn JR, Williams JB. 2012. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: Oxidative stress and the seesaw of cell survival and death. Comp Biochem Physiol B Biochem Mol Biol 163:26-36.
54. Wang X, Blagden C, Fan J, Nowak SJ, Taniuchi I, Littman DR, Burden SJ. 2005. Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. Genes Dev 19:1715-1722.
55. Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, Wenk MR, Ong CN, Codogno P, Shen HM. 2010. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem 285:10850-10861.
56. Yoshida CA, Furuichi T, Fujita T, Fukuyama R, Kanatani N, Kobayashi S, Satake M, Takada K, Komori T. 2002. Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 32:633-638.
57. Young MM, Kester M, Wang HG. 2013. Sphingolipids: Regulators of crosstalk between apoptosis and autophagy. J Lipid Res 54:5-19.
58. Zheng W, Kollmeyer J, Symolon H, Momin A, Munter E, Wang E, Kelly S, Allegood JC, Liu Y, Peng Q, Ramaraju H, Sullards MC, Cabot M, Merrill AH Jr. 2006. Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta 1758:1864-1884.